amir viyanchi
Shahid Beheshti University of Medical Scineces,Tehran,Iran.
[ 1 ] - Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...
[ 2 ] - Selecting the acceptance criteria of medicines in the reimbursement list of public health insurance of Iran, using the “Borda”method: a pilot study
Decision-making for medicines to be accepted in Iran’s public health insurance reimbursement list is a complex process and involves factors, which should be considered in applying a coverage for medicine costs. These processes and factors are not wholly assessed, while assessment of these factors is an essential need for getting a transparent and evidence-based approach toward medicine reimburs...
[ 3 ] - Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...
[ 4 ] - Selecting the acceptance criteria of medicines in the reimbursement list of public health insurance of Iran, using the “Borda”method: a pilot study
Decision-making for medicines to be accepted in Iran’s public health insurance reimbursement list is a complex process and involves factors, which should be considered in applying a coverage for medicine costs. These processes and factors are not wholly assessed, while assessment of these factors is an essential need for getting a transparent and evidence-based approach toward medicine reimburs...
[ 5 ] - بررسی پوشش بیمهای دارو در ایران در مقایسه با کشورهای منتخب
Introduction: in Iran, the compilation council of drug, having an advisory role, is responsible to cover medicine costs for health insurances. Health Insurance High Council also acts as the final decision maker about the admission of new drugs. This article studies how new drugs in Iran's health insurances are covered compared with some selected countries. Methods: After collecting drug accep...
Co-Authors